Parkinson’s disease grafts benefit from well-timed growth factor

Lorenz Studer () and Viviane Tabar ()

Nature, 2020, vol. 582, issue 7810, 39-40

Abstract: Grafts of stem-cell-derived precursors of dopamine neurons could be used to treat Parkinson’s disease, but this approach has limitations. Injecting a growth factor three weeks after transplantation can overcome some of these limits.

Keywords: Parkinson's disease; Medical research; Neurodegeneration (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-020-01486-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:582:y:2020:i:7810:d:10.1038_d41586-020-01486-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-01486-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().